Robert Croop Selected Research

Therapeutics

10/2022	Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial.
1/2021	Novel acute therapies in the treatment of migraine: impact of re-dosing on cost-utility outcomes.
1/2021	Matching-adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health-related quality of life in the treatment of migraine.
1/2020	Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Croop Research Topics

Disease

25	Migraine Disorders (Migraine) 04/2024 - 01/2019
9	Pain (Aches) 04/2024 - 01/2019
3	Nausea 01/2023 - 01/2019
2	Chemical and Drug Induced Liver Injury 04/2024 - 04/2024
2	Urinary Tract Infections (Urinary Tract Infection) 01/2023 - 01/2019
2	Dizziness (Lightheadedness) 11/2022 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 03/2012
1	Photophobia (Light Sensitivity) 01/2023
1	Hyperacusis (Phonophobia) 01/2023
1	Sleepiness 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Cognitive Dysfunction 01/2013
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 06/2009
1	Alcoholism (Alcohol Abuse) 12/2002

Drug/Important Bio-Agent (IBA)

23	rimegepant sulfateIBA 04/2024 - 01/2019
17	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 04/2024 - 01/2019
4	TabletsIBA 04/2024 - 01/2019
4	Calcitonin Gene-Related PeptideIBA 10/2022 - 01/2020
3	lasmiditanIBA 11/2022 - 11/2020
3	ubrogepantIBA 11/2022 - 11/2020
3	erenumabIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
2	Nasal SpraysIBA 01/2023 - 10/2022
2	galcanezumabIBA 01/2021 - 09/2020
2	Monoclonal AntibodiesIBA 09/2020 - 01/2020
2	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2020 - 11/2019
1	N-acetyltryptophanamide (NATA)IBA 04/2024
1	Tryptamines (Triptans)IBA 01/2023
1	Quinidine (Chinidin)FDA LinkGeneric 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	LigandsIBA 09/2020
1	fremanezumabIBA 09/2020
1	BMS 708163IBA 01/2013
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2012
1	Amyloid (Amyloid Fibrils)IBA 03/2012
1	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2009
1	Naltrexone (ReVia)FDA LinkGeneric 12/2002
1	EnzymesIBA 12/2002

Therapy/Procedure

4	Therapeutics 10/2022 - 01/2020
1	Aftercare (After-Treatment) 01/2023